Author Archives: jdyork

Secretary Thompson focuses on developing solutions for clients in the health care industry, as well as for companies doing business in the public sector. Before entering the private sector in 2005, Secretary Thompson enjoyed a long and distinguished career in … Continue reading →

In the fall of 1995, Mr. Sprague was diagnosed with chronic myelogenous leukemia. Unfortunatley, after 18 months of chemotherapy and in desperate need of a bone marrow transplant, he found himself in “blast crisis”—the end stage of his disease. An … Continue reading →

Dr. Nimer is currently vice chairman for Faculty Development within the Department of Medicine at Memorial Sloan-Kettering Cancer Center (MSKCC), a member of the Sloan-Kettering Institute for Cancer Research and professor of medicine and pharmacology at Weill Medical College of … Continue reading →

At 38 years of age, Mrs. Porter, a once healthy young mother, was diagnosed with systemic scleroderma, a devastating autoimmune disorder. She started experiencing Reynaud’s disease, tightness of the skin especially in her hands that became swollen, contractured, and ulcerated. … Continue reading →

Dr. Smith joined NeoStem, Inc., as chairman of its Advisory Board in September 2005 and, effective June 2, 2006, became the chief executive officer and chairman of the Board of Directors. Dr. Smith, who received a medical degree from Yale … Continue reading →

As the founder and chief executive officer of Celgene Cellular Therapeutics, Dr. Hariri pioneered the use of human stem cells to treat a range of life-threatening diseases. In his career as neurosurgeon and trauma specialist at Cornell University, biotechnology executive, … Continue reading →

Dr. Preti is Progenitor Cell Therapy, LLC’s (PCT) co-founder, president, and chief scientific officer. Through his administrative duties, Dr. Preti has overseen the growth of PCT from its inception to its position as a world-leading commercial cell therapy company. Previous … Continue reading →

Dr. Burt is chief of the Division of Immunotherapy, Department of Medicine, Feinberg School of Medicine, Northwestern University. Dr. Burt pioneered the use of hematopoietic stem cells to treat autoimmune diseases. Dr. Burt performed either America’s first or the world’s … Continue reading →

Rev. Trafny completed his studies in philosophy and theology at the Catholic University of Lublin. Ordained as a priest in 1996 for the Archdiocese of Lublin, he served as a parish assistant in Kazimierz Dolny (Archdiocese of Lublin), as a … Continue reading →

Dr. Sloan is professor emeritus in the Program of Liberal Studies, University of Notre Dame’s “Great Books” department and in the graduate program in history and philosophy of science at Notre Dame. Dr. Sloan has also been active as a … Continue reading →